Clinical Research Directory
Browse clinical research sites, groups, and studies.
Detection of Minimal Residual Disease Post-prostatectomy
Sponsor: Radboud University Medical Center
Summary
The clinical objective for this pilot study is to determine whether minimal residual disease (MRD) detection in high-risk prostate cancer, utilizing a custom-made prostate-specific circulating tumor DNA (ctDNA) panel, may lead to more optimal prediction of disease recurrence following radical prostatectomy.
Official title: Pilot Study for the Detection of Minimal Residual Disease Post-prostatectomy and Early Disease Recurrence in Circulating Tumor DNA to Guide Future Adjuvant Therapy in High-risk Prostate Cancer Patients (MiRaDE)
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2025-09-16
Completion Date
2028-01
Last Updated
2026-01-12
Healthy Volunteers
No
Conditions
Locations (1)
Prosper Prostate Cancer Clinics
Nijmegen, Netherlands